It is a multidisciplinary unit that diagnoses and medically or surgically treats benign and malignant diseases of the colon, rectum and anus.
It has advanced technology with a 4K and 3D vision system, which allows, in most cases, to carry out interventions with minimally invasive surgery. The result is a quick recovery with little aesthetic repercussion.

Colorectal cancer is the most prevalent pathology (the service carries out more than 250 interventions of this type annually), followed by proctological diseases (hemorrhoids, fissures and fistulas, and sacral cyst).

Devices and facilities:

• 5 weekly sessions of central operating theaters for highly complex pathologies.
• 2 weekly sessions for major surgery pathologies without admission.
• 1 fortnightly session of outpatient minor surgery (proctology).
• 1 fortnightly session of the endoanal testing room (ultrasound and anal cancer diagnosis).
• 48 hours per week of external consultation.

Procedures and assistance lines:
• The Colorectal Cancer Functional Unit offers rapid, comprehensive, continuous and humanized care to patients suspected of having colorectal cancer. It achieves a diagnosis-treatment interval of less than 30 days in more than 80% of cases. The Colorectal Cancer Rapid Diagnosis Unit (UDR), led by clinical nurses, allows a quick, high-quality and satisfactory response.
• Multidisciplinary committee for the diagnostic and treatment decision of patients with colorectal cancer.
• Application of the Fastrack system in the surgical treatment of colorectal surgeries.
• Experience and technology in transanal endoscopy microsurgery for the treatment of rectal tumors at the earliest stage.
• Home hospitalization unit for the treatment of acute diverticulitis.
• The Inflammatory Bowel Disease Functional Unit and the Pelvic Floor Functional Unit offer multidisciplinary and comprehensive care in these less prevalent pathologies. This requires active collaboration with services such as Digestology, Urology, Gynaecology, Radiology, Oncology and Pathological Anatomy.
• The specific and personalized coloproctology consultation allows individualized attention in proctology pathology and with current technology.
• Pelvic Sun Unit for the treatment of complex pelvic sun diseases.
• The population triage program for colorectal cancer, together with the Digestology Service, allows patients affected by colorectal cancer to be treated at a much earlier stage and, therefore, obtain better results.
• Endorectal Ultrasound Diagnostic Unit for the study of rectal tumors and benign proctological diseases.
• Anus cancer detection program in patients at risk.
• Integration in the pioneering blood saving project (directed by Internal Medicine) for anemic patients and those affected by colorectal cancer.

It is a multidisciplinary unit that diagnoses and surgically treats benign and malignant diseases of the endocrine glands, stomach and esophagus.

It has advanced technology with a 4K and 3D vision system, which allows the indicated surgical procedures to be carried out with minimally invasive surgery.

Devices and facilities:
• 6 weekly sessions of central operating theatres.
• 24 hours per week of external consultation.

Procedures and assistance lines:
• The Functional Unit of Esophagogastric Tumors and the Functional Unit of the Endocrine Glands offer rapid, comprehensive, continuous and humanized care to patients suspected of having stomach and esophageal cancer. They achieve a diagnosis-treatment interval of less than 30 days in more than 80% of cases.
• Surgery for esophageal neoplasia is not part of our institution's portfolio of services and if surgery is needed, cases are referred to Bellvitge University Hospital following a continuum of care.
• Multidisciplinary committee led by clinical nursing for the diagnostic and treatment decision of patients with oesophagogastric and endocrine gland cancer.
• Integration in the pioneering blood saving project (directed by Internal Medicine) for anemic patients and those affected by esophageal and gastric cancer.
• Minimally invasive surgery for benign and malignant gastric diseases.

It is a multidisciplinary team that diagnoses and medically or surgically treats benign and malignant diseases of the liver, bile ducts and pancreas.
It has surgical technology (4K and 3D vision) and advanced endoscopic technology that allows, in most cases, to carry out minimally invasive procedures.

Devices and facilities:
• 4 weekly sessions of central operating theatres
• 24 hours a week of external consultation

Procedures and assistance lines:
• The Liver, Pancreas and Biliary Tract Tumors Functional Unit offers rapid, comprehensive, continuous and humanized care to patients who are suspected of having cancer of the liver, pancreas and biliary tract. It achieves a diagnosis-treatment interval of less than 30 days in more than 80% of cases.
• Neoplastic pathology of the liver and bile ducts and pancreas that requires surgical intervention is referred to the Bellvitge University Hospital, to offer continuity of care.
• Multidisciplinary hepatobiliopancreatic tumor committee made up of surgeons, digestologists and oncologists, which also includes clinical nursing, for the diagnostic and treatment decision of patients with cancer of the liver, pancreas and bile ducts.
• Cholecystectomy program in ambulatory surgery, which represents 20% of elective cholecystectomies.
• Clinical pathway to implement the early discharge of mild acute pancreatitis.
• The most prevalent pathology is biliary tract lithiasis, with more than 500 cholecystectomies and 130 procedures on the biliary tract.
• Early surgical treatment program for acute pancreatitis of biliary origin.
• Laparoscopic surgery program for choledocholithiasis associated with cholelithiasis.

It is a multidisciplinary unit that diagnoses and treats benign and malignant pathology of the mammary gland.

The Hospital de Sant Joan Despí Moisès Broggi and the Hospital General de l'Hospitalet have the resources to provide comprehensive care: triage, diagnosis (stereotaxic mammography, interventional nuclear magnetic resonance), surgical and/or oncological treatment, psychotherapy and finally , when necessary, immediate or deferred reconstructive surgery.

Breast cancer is a very prevalent disease, with more than 200 interventions per year.

Devices and facilities:
• 3 weekly sessions of central operating theatres.
• 20 hours per week of external consultation.

Procedures and assistance lines:
• The Functional Breast Unit offers rapid, comprehensive, continuous and humanized care to patients suspected of having breast cancer. It achieves a diagnosis-treatment interval of less than 30 days in more than 80% of cases. It is made up of: Diagnostic Imaging, Oncology, Surgery, Gynecology and Plastic Surgery. The Breast Cancer Rapid Diagnosis Unit, led by clinical nursing, is a basic instrument to achieve these results with humanized care.
• It has the most advanced diagnostic systems for an accurate diagnosis.
• The integration and collaboration with the Plastic Surgery Service makes it possible to offer, in the indicated cases, immediate or delayed reconstruction with microsurgery, pendants or prosthetics.
• Coordination with primary care allows for continuity of care and a much more humanized treatment.

It is a surgical team specialized in the treatment of abdominal wall repair. His long experience and the incorporation of the most advanced technology allow him to respond to the complex abdominal pathology of indentations and hernias. It is a center of reference in Catalonia and provides technical support to highly complex cases from other health institutions in the community.

Devices and facilities:
• 5 weekly sessions of central operating theatres.
• 18 hours per week of external consultation.
• 2 sessions of major outpatient surgery.
• It has the technology for minimally invasive surgery.

Procedures and assistance lines:
• Consolidation and development of the abdominal wall repair technique by minimally invasive surgery.
• The team offers the preoperative pneumoperitoneum procedure in the context of home hospitalization for the subsequent treatment of very complex hernias with loss of home.

It is a virtual unit made up of professionals from the various units in charge of the surgical treatment of procedures without admission. It is mostly carried out at the Hospital General de l'Hospitalet.

More than 1.800 procedures are surgically diagnosed and treated: inguinal hernia, cholecystectomies, umbilical hernias, hemorrhoids, fistulas, fissures, sacral cysts, lipomas, and placement of intravenous devices for the administration of chemotherapy.

Devices and facilities:
• 7 weekly sessions for major surgery pathologies without admission.

Procedures and assistance lines:
• Cholecystectomy program in ambulatory surgery, which represents 20% of elective cholecystectomies.
• Proctological ambulatory surgery program.

Plastic surgery is a peculiar specialty since it does not treat a single organ, system or a defined anatomical area. It is defined as a branch of surgery that deals with the surgical correction of any congenital, acquired, tumoral or involutional process that requires the repair or replacement of structures that affect the body's form and/or function. Its techniques are based on tissue transplantation and mobilization.

In recent years, plastic surgery has experienced an exponential development of surgical techniques in order to achieve the best quality and satisfaction for patients.

The plastic surgery team therefore deals with surgical diseases of the skin, breast, head and neck area or limbs but, above all, collaborates with the other specialties to provide a solution to tumor processes that require tissue repair or replacement.

To carry out these surgeries, the Service has the most advanced technology that allows it to perform complex reconstructive techniques such as reconstruction with vascular microsurgery.

The team works simultaneously at the Sant Joan Despí Hospital, the Hospital General de l'Hospitalet and the Bellvitge University Hospital.
It is organized into teams:

• Breast pathology team.
• Skin pathology team.
• Head and neck pathology team
• Extremity pathology team.

Devices and facilities:
• 1,5 weekly sessions of central operating theaters for highly complex pathologies.
• 1,5 weekly sessions for major surgery pathologies without admission.
• 3,5 weekly operating room sessions for minor outpatient surgery.
• 18 hours per week of external consultation.

Procedures and assistance lines:
• Oncological and reconstructive surgery for tumors of the soft parts.
• Oncological and reconstructive surgery for skin tumors and melanoma.
• Oncological and reconstructive surgery of the mammary gland
• Reconstructive surgery for traumatic pathology and chronic wounds.
• Microsurgery unit.
• Surgery for the sequelae of morbid obesity.
• Disciplinary committee of breast pathology.
• Multidisciplinary skin pathology committee.
• Multidisciplinary head and neck pathology committee.

It is responsible for the management and assistance of all surgical pathologies within the area of ​​the specialized care centers affiliated to the Hospital (CAE Cornellà de Llobregat, CAE Sant Feliu de Llobregat and CAE Ronda la Torrassa) derived from the care primary and post-operative control of patients with less complex surgery so that the patient can be cared for closer to home.

Devices and facilities:
• 3 weekly operating room sessions for minor outpatient surgery.
• 45 hours per week of external consultation.

Procedures and assistance lines:
• Oncological and reconstructive surgery for tumors of the soft parts.

Sant Joan Despí Hospital is the center of reference in Catalonia and other autonomous communities of the Spanish State in the radical treatment of peritoneal carcinomatosis through the combined use of radical surgery (CRS) and peritoneal chemohyperthermia, known as in CRS+HIPEC or Sugarbaker technique.
Since the beginning of its activity, the team has provided assistance representing the Peritoneal Carcinomatosis Program of Catalonia with the support of a scientific-care collaboration agreement with the Catalan Institute of Oncology (ICO) and under the auspices of the health authorities and the Oncology Master Plan.

Currently, this Carcinomatosis Program is the most active, in terms of care, nationally and of those with greater experience in the international arena. Since its inception in 2006, it has performed more than 1.200 CRS + HIPEC treatments and another 1.000 CRS cases.

The Peritoneal Carcinomatosis Program of Catalonia is one of the few projects of this type with results evaluated by external agencies and Catalonia's own health authorities. The results obtained regarding the effectiveness and safety of the treatment are equivalent to those described by the best international centers of reference in the management of this pathology.

Devices and facilities:
• 4 weekly sessions of central operating theatres.
• 12 hours per week of external consultation.
• Weekly clinical session.
• Multidisciplinary committee of peritoneal tumors (weekly meeting).

Procedures and assistance lines:
• Radical treatment of the different types of peritoneal carcinomatosis with evidence of benefit with CRS+HIPEC:

– Peritoneal pseudomyxoma.
– Peritoneal mesothelioma.
– Peritoneal carcinomatosis of colorectal origin.
– Advanced ovarian cancer. Peritoneal carcinomatosis of ovarian origin.
– Peritoneal carcinomatosis of gastric origin.
– Peritoneal sarcomatosis.
– Peritoneal carcinomatosis of infrequent origin.

• Treatment of pleuropulmonary mucinous disease of peritoneal pseudomyxoma.
• Advanced oncological surgery: radical cytoreductions associated with multivisceral resections in primary tumor surgery.
• Minimally invasive (laparoscopic) cytoreductive surgery for low-volume peritoneal metastases.
• Minimally invasive gastrectomy (laparoscopy) for gastric cancer with low-volume peritoneal metastases.
• Retroperitoneal tumors.
• Pelvic exenterations that require urinary, pelvic floor and perineal repair.
• Surgical management of complex tumor recurrences.
• Abdominal complications of radiotherapy: complex adhesion processes, fistulas, septic complications.

The surgical team has extensively developed the use of peritonectomy procedures for their application in complex approach situations in oncological, reconstructive or repair surgery for digestive and/or urinary injuries.

The bariatric surgery team works together with other professionals dedicated to the treatment of obesity and associated comorbidities in a specialized multidisciplinary unit.

He performs primary bariatric surgery (vertical gastrectomy, gastric bypass, SADI-S, duodenal bypass), metabolic surgery and revisional surgery. It has an intraoperative endoscopy team and advanced laparoscopic technology, with a 4K and 3D vision system, which allow most minimally invasive interventions to be carried out.

Devices and facilities:
• 2 weekly sessions of central operating theatres.
• 10 hours per week of external consultation.

Procedures and assistance lines:
• Active participation in the Obesity and Bariatric Surgery Unit, which offers a comprehensive, humane and continuous treatment of obesity and its associated comorbidities according to the guidelines of the Catalan Health Service.
• Active participation in the multidisciplinary committee of the UOCB to speed up diagnostic and therapeutic decisions for patients with obesity and associated comorbidities.
• Primary bariatric surgery (vertical gastrectomy, gastric bypass, SADI-S, duodenal bypass), metabolic surgery and revisional surgery, with minimally invasive approaches and intraoperative endoscopic support.
• Systematic application of early discharge strategies, with a usual postoperative stay of less than three days.
• Intensified ambulatory follow-up during the first year and long-term follow-up of all bariatric surgery patients.

It is a comprehensive and multidisciplinary care area for frail patients who require surgical intervention. It is about providing individualized care, optimizing the patients' condition prior to the surgical intervention and finding and putting in place all the resources, both intra- and extra-hospital, that the patient will need throughout their care process. This allows to reduce complications, stay and maintain the quality of life with a satisfactory doctor-patient relationship.

The team is designing a learning system using a surgical video processor to facilitate surgical maneuvers for resident physicians and novice surgeons.

The esophagogastric section is part of the Eureca project for the study and quality control of this type of tumour.

• Multicenter research study of the early treatment of lithiasis in patients with pancreatitis led by our hospital.
• Multicenter study of early nutrition in mild acute pancreatitis (PADI).
• Alternative methods for the treatment of pain in mild acute pancreatitis.

Project on the use of preoperative botulinum toxin in complex wall pathologies.

A post-operative control and follow-up system for the patient via telematics is being designed in order to avoid having to travel to hospitals once the intervention has already taken place.

• "In house" planning of reconstruction with vascularized bone grafts.
• ERAS program in reconstruction with microsurgery.

Members of the unit regularly perform retrospective and prospective clinical studies and have presented their work at numerous International conferences.
The unit is an active research center in the following multi-institutional clinical trials:

• HIPEC T4. Multicenter randomized clinical trial to evaluate the efficacy and safety of hyperthermic intraperitoneal chemotherapy (HIPEC) with Mitomycin C associated with surgery in the treatment of locally advanced colorectal carcinoma.

• EuroPMP
COST Action. European Cooperation in Science & Technology
CA17101: European network on Pseudomyxoma Peritonei.

• International Multicentric European Accelerator study, Pseudomyxoma peritonei: building a European multicentric cohort to accelerate new therapeutic perspective.
Cancer Research UK (CRUK), Spanish Association against Cancer (AECC) & Italian Association for Research on Cancer (AIRC) (Consortium).

• Incorporation of new technologies in learning and dissemination of knowledge related to bariatric and metabolic surgery.
• Analyzes and optimization of weight metrics.